Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients
Allison W. Kurian(Stanford University), Steven J. Katz(University of Michigan), Angela B. Mariotto(National Cancer Institute), Kevin C. Ward(Emory University), Daniel Miller(Information Management Services), Nadia Howlader(National Cancer Institute), Ann S. Hamilton(University of Southern California), Lynne S. Penberthy(National Cancer Institute), Dennis Deapen(University of Southern California)
Cited by 383
Related Papers
The Effect of Advances in Lung-Cancer Treatment on Population Mortality
|New England Journal of Medicine|2020|1.7k
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660